» Authors » Giorgio Corte

Giorgio Corte

Explore the profile of Giorgio Corte including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 1419
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, Moroni C, et al.
PLoS Biol . 2015 Nov; 13(11):e1002314. PMID: 26569611
No abstract available.
2.
Giannoni P, Scaglione S, Quarto R, Narcisi R, Parodi M, Balleari E, et al.
Haematologica . 2011 Apr; 96(7):1015-23. PMID: 21486864
Background: Chronic lymphocytic leukemia cells are characterized by an apparent longevity in vivo which is lost when they are cultured in vitro. Cellular interactions and factors provided by the microenvironment...
3.
Paina S, Garzotto D, DeMarchis S, Marino M, Moiana A, Conti L, et al.
J Neurosci . 2011 Feb; 31(7):2675-87. PMID: 21325536
During brain development, neurogenesis, migration, and differentiation of neural progenitor cells are regulated by an interplay between intrinsic genetic programs and extrinsic cues. The Dlx homeogene transcription factors have been...
4.
Monticone M, Bisio A, Daga A, Giannoni P, Giaretti W, Maffei M, et al.
J Cell Biochem . 2010 Aug; 111(5):1149-59. PMID: 20683904
Demethyl fruticulin A (SCO-1) is a compound found in Salvia corrugata leaves. SCO-1 was reported to induce anoikis in cell lines via the membrane scavenging receptor CD36. However, experiments performed...
5.
Melotti A, Daga A, Marubbi D, Zunino A, Mutti L, Corte G
BMC Cancer . 2010 Feb; 10:54. PMID: 20175889
Background: Malignant pleural mesothelioma is a rare disease known to be resistant to conventional therapies. A better understanding of mesothelioma biology may provide the rationale for new therapeutic strategies. In...
6.
Favoni R, Pattarozzi A, Lo Casto M, Barbieri F, Gatti M, Paleari L, et al.
Curr Cancer Drug Targets . 2010 Jan; 10(2):176-91. PMID: 20088784
Altered EGFR activity is a causal factor for human tumor development, including malignant pleural mesotheliomas. The aim of the present study was the evaluation of the effects of Gefitinib on...
7.
Monticone M, Biollo E, Fabiano A, Fabbi M, Daga A, Romeo F, et al.
Mol Cancer Res . 2009 Oct; 7(11):1822-34. PMID: 19861404
Gamma-secretase inhibitors have been proposed as drugs able to kill cancer cells by targeting the NOTCH pathway. Here, we investigated two of such inhibitors, the Benzyloxicarbonyl-Leu-Leu-Nle-CHO (LLNle) and the N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine...
8.
Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, et al.
Mol Cancer Res . 2009 Mar; 7(3):383-92. PMID: 19276180
It has been reported that cancer stem cells may contribute to glioma radioresistance through preferential activation of the DNA damage checkpoint response and an increase in DNA repair capacity. We...
9.
Castriconi R, Daga A, Dondero A, Zona G, Poliani P, Melotti A, et al.
J Immunol . 2009 Mar; 182(6):3530-9. PMID: 19265131
In this study, cancer cells were isolated from tumor specimens of nine glioblastoma patients. Glioblastoma cells, cultured under suitable culture conditions, displayed markers typical of neural stem cells, were capable...
10.
Appolloni I, Calzolari F, Tutucci E, Caviglia S, Terrile M, Corte G, et al.
Int J Cancer . 2009 Jan; 124(10):2251-9. PMID: 19165863
We describe the generation of mouse gliomas following the overexpression of PDGF-B in embryonic neural progenitors. Our histopathological, immunohistochemical and genome-wide expression analyses revealed a surprising uniformity among PDGF-B induced...